North America Toxicology Laboratories Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America)

North America Toxicology Laboratories Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America)


The North America Toxicology Laboratories Market is experiencing robust growth, with revenues reaching US$ 220 Mn in 2024, and expected to drive the market to approximately US$ 600 Mn by the end of 2031, as per the latest analysis report by Fairfield Market Research.

Rapid Advancements in Toxicology Laboratories

Toxicology laboratories in North America are undergoing significant technological advancements, primarily driven by the escalating demand for drug toxicity testing, especially for controlled substances. Manufacturers are increasingly utilizing high-throughput screening assays, such as ""rapid chemical screening technologies,"" to efficiently assess the impact of various chemicals on human health and the environment while reducing the reliance on laboratory animal-based toxicity tests.

Shift to Rapid Testing Techniques

Small-scale toxicology laboratories in North America are transitioning from slower testing procedures to more rapid testing techniques. This shift is attributed to the growing demand in the region and the need for quicker and more efficient testing methods.

Stringent Regulatory Standards

Stringent regulatory standards imposed by government authorities to curb the misuse of restricted substances have led to an increased adoption of toxicology testing in North America. Regulations like the United States Prohibited Substances Act and the Controlled Substances Act have established a comprehensive legal framework to regulate controlled substances. Drug testing of employees and toxicological tests by insurance providers are mandated under these regulations.

Advanced Equipment and Techniques

Toxicology laboratories are increasingly relying on sensitive and specialized equipment, such as liquid chromatography-mass spectrometry (LC-MS), to analyze complex molecular structures. This advancement allows for precise targeting, screening, and quantitative determination of analytes in biological matrices.

Factors Fueling Global Market Growth

To enhance their market positions, businesses in the toxicology laboratories market are pursuing various strategies, including partnerships, acquisitions, and collaborations with smaller companies in the industry. Technological advancements and the adoption of cloud-based systems are also contributing to market growth.

Market Growth Challenges

The emergence of point-of-care toxicology testing devices could potentially affect the North America Toxicology Laboratories Market by diverting market share from traditional laboratories. Traditional toxicological testing, while prevalent, can be costly and less efficient, necessitating confirmatory tests.

Booming U.S. Market

The United States is witnessing substantial growth in the toxicology laboratories market due to increased consumer awareness and a significant consumption of controlled substances in the country. The demand for traditional toxicological testing equipment remains high in the U.S.

Market Outlook in Canada

Canada's toxicology laboratories face heightened demands due to the recent legalization of cannabis and the opioid crisis, exacerbated by the COVID-19 pandemic. Forensic labs in Canada are under pressure to meet increased testing requirements.

Competition Landscape

Leading instrument and reagent manufacturers in the toxicology laboratories market are focusing on introducing new products to enhance their core competencies. Companies are making strategic adjustments to deliver efficient and time-sensitive results.

Key Companies Profiled
• Thermo Fisher Scientific, Inc
• Danaher Corporation
• Agilent Technologies
• Alere, Inc.
• Bio Rad Laboratories Inc.
• Neogen Corporation
• Bruker
• WATERS
• Redwood Toxicology Laboratory
• Laboratory Corporation of America ©Holdings (MedTox Laboratories, Inc.)
• Principle Laboratory
• Pacific Toxicology Laboratories
• Medical Toxicology Laboratory, LLC
• ITR Canada
• NMS Labs
• National Toxicology Labs, Inc
• BATTS Laboratories
• Marshfield Clinic.
• TOTAL TOXICOLOGY LABS
• Clinical Reference Laboratory, Inc.
• Life Brite Labs.
• Product Safety Labs
• Lexar Labs,
• Eurofins Scientific
• Aegis Sciences Corporation
• Enzo Life Sciences, Inc.
• Immunalysis Corporation
• Vala Sciences, Inc.
• Mattek Corporation
• MedTest Dx
• Pyxis Laboratories Inc.
• Air Science® USA LLC.

Market Segmentation

Drug Class:
• Alcohol
• Amphetamines
• Barbiturates
• Benzodiazepines
• Illicit Drugs
• Opiates/Opioids
• Tricyclic’s Antidepressants
• Z Drugs

Product:
• Reagent and Kits
ELISA
PCR
Enzyme Multiplied Immunoassay Technique (EMIT)
Radio Immuno-sorbent Assay (RIA)
• Instruments
Immunochemistry Analyzers
PCR Machine
Gas Chromatography/Mass Spectrometry (GS/MS)
High Performance Liquid Chromatography(HPLC)

Sample:
• Urine
• Blood
• Hair
• Oral Fluid

End User:
• Hospitals
• Clinics
• Diagnostic Laboratories
• Forensic Laboratories
• Rehabilitation Centers

Country:
• U.S.
• Canada

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.


1. Executive Summary
1.1. North America Toxicology Laboratories Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. North America Toxicology Laboratories Market Outlook, 2018 – 2031
3.1. North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2018 – 2031
3.1.1. Key Highlights
3.1.1.1. Alcohol
3.1.1.2. Amphetamines
3.1.1.3. Barbiturates
3.1.1.4. Benzodiazepines
3.1.1.5. Illicit Drugs
3.1.1.6. Opiates/Opioids
3.1.1.7. Tricyclic’s Antidepressants
3.1.1.8. Z Drugs
3.1.1.9. Others
3.2. North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2018 – 2031
3.2.1. Key Highlights
3.2.1.1. Reagent Kits
3.2.1.1.1. ELISA
3.2.1.1.2. PCR
3.2.1.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
3.2.1.1.4. Radio Immuno-sorbent Assay (RIA)
3.2.1.2. Instruments
3.2.1.2.1. Immunochemistry Analyzers
3.2.1.2.2. PCR Machine
3.2.1.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
3.2.1.2.4. High Performance Liquid Chromatography (HPLC)
3.3. North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2018 – 2031
3.3.1. Key Highlights
3.3.1.1. Urine
3.3.1.2. Blood
3.3.1.3. Hair
3.3.1.4. Oral Fluid
3.3.2. Market Attractiveness Analysis
3.4. North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2018 – 2031
3.4.1. Key Highlights
3.4.1.1. U.S. Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 – 2031
3.4.1.2. U.S. Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 – 2031
3.4.1.3. U.S. Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 – 2031
3.4.1.4. Canada Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 – 2031
3.4.1.5. Canada Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 – 2031
3.4.1.6. Canada Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 – 2031
3.4.2. Market Attractiveness Analysis
4. Competitive Landscape
4.1. Manufacturer vs Product Type/Drug Class Heatmap
4.2. Company Market Share Analysis, 2023
4.3. Competitive Dashboard
4.4. Company Profiles
4.4.1. Thermo Fisher Scientific
4.4.1.1. Company Overview
4.4.1.2. Product Portfolio
4.4.1.3. Financial Overview
4.4.1.4. Business Strategies and Development
4.4.2. Bio-Rad Laboratories, Inc.
4.4.2.1. Company Overview
4.4.2.2. Product Portfolio
4.4.2.3. Financial Overview
4.4.2.4. Business Strategies and Development
4.4.3. NEOGEN Corporation
4.4.3.1. Company Overview
4.4.3.2. Product Portfolio
4.4.3.3. Financial Overview
4.4.3.4. Business Strategies and Development
4.4.4. Redwood Toxicology Laboratory, Inc.
4.4.4.1. Company Overview
4.4.4.2. Product Portfolio
4.4.4.3. Financial Overview
4.4.4.4. Business Strategies and Development
4.4.5. Vala Sciences, Inc.
4.4.5.1. Company Overview
4.4.5.2. Product Portfolio
4.4.5.3. Financial Overview
4.4.5.4. Business Strategies and Development
4.4.6. Enzo Life Sciences, Inc.
4.4.6.1. Company Overview
4.4.6.2. Product Portfolio
4.4.6.3. Financial Overview
4.4.6.4. Business Strategies and Development
4.4.7. Alere, Inc.
4.4.7.1. Company Overview
4.4.7.2. Product Portfolio
4.4.7.3. Financial Overview
4.4.7.4. Business Strategies and Development
4.4.8. Agilent Technologies, Inc.
4.4.8.1. Company Overview
4.4.8.2. Product Portfolio
4.4.8.3. Financial Overview
4.4.8.4. Business Strategies and Development
4.4.9. Immunalysis Corporation
4.4.9.1. Company Overview
4.4.9.2. Product Portfolio
4.4.9.3. Financial Overview
4.4.9.4. Business Strategies and Development
4.4.10. Danaher Corporation
4.4.10.1. Company Overview
4.4.10.2. Product Portfolio
4.4.10.3. Financial Overview
4.4.10.4. Business Strategies and Development
4.4.11. Principle Diagnostics Laboratory
4.4.11.1. Company Overview
4.4.11.2. Product Portfolio
4.4.11.3. Financial Overview
4.4.11.4. Business Strategies and Development
4.4.12. Principle Laboratory
4.4.12.1. Company Overview
4.4.12.2. Product Portfolio
4.4.12.3. Financial Overview
4.4.12.4. Business Strategies and Development
4.4.13. Principle Diagnostics Laboratory
4.4.13.1. Company Overview
4.4.13.2. Product Portfolio
4.4.13.3. Financial Overview
4.4.13.4. Business Strategies and Development
4.4.14. Clinical Reference Laboratory, Inc.
4.4.14.1. Company Overview
4.4.14.2. Product Portfolio
4.4.14.3. Financial Overview
4.4.14.4. Business Strategies and Development
4.4.15. Medical Toxicology Laboratory, LLC
4.4.15.1. Company Overview
4.4.15.2. Product Portfolio
4.4.15.3. Financial Overview
4.4.15.4. Business Strategies and Development
4.4.16. NMS Labs
4.4.16.1. Company Overview
4.4.16.2. Product Portfolio
4.4.16.3. Financial Overview
4.4.16.4. Business Strategies and Development
4.4.17. BATTS Laboratories
4.4.17.1. Company Overview
4.4.17.2. Product Portfolio
4.4.17.3. Financial Overview
4.4.17.4. Business Strategies and Development
4.4.18. Total Toxicology
4.4.18.1. Company Overview
4.4.18.2. Product Portfolio
4.4.18.3. Financial Overview
4.4.18.4. Business Strategies and Development
4.4.19. Life Brite Labs.
4.4.19.1. Company Overview
4.4.19.2. Product Portfolio
4.4.19.3. Financial Overview
4.4.19.4. Business Strategies and Development
4.4.20. Product Safety Labs
4.4.20.1. Company Overview
4.4.20.2. Product Portfolio
4.4.20.3. Financial Overview
4.4.20.4. Business Strategies and Development
4.4.21. Lexar Labs
4.4.21.1. Company Overview
4.4.21.2. Product Portfolio
4.4.21.3. Financial Overview
4.4.21.4. Business Strategies and Development
5. Appendix
5.1. Research Methodology
5.2. Report Assumptions
5.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings